Hepatitis C Knowledge among Primary Care Residents: Is Our Teaching Adequate for the Times?

Coppola, Angelo G.; Karakousis, Pietor C.; Metz, David C.; Go, Mae F.; Mhokashi, M; Howden, Colin W.; Raufman, Jean-Pierre; Sharma, Virender K.
September 2004
American Journal of Gastroenterology;Sep2004, Vol. 99 Issue 9, p1720
Academic Journal
BACKGROUND: Increasingly, primary care (PC) physicians will be the first to encounter patients with hepatitis C virus (HCV) infection.AIM: To determine opinions and practices of PC residents regarding HCV.METHODS: We administered a one-page questionnaire to 180 PC residents at five U.S. training programs.RESULTS: Respondents were distributed equally across postgraduate year, 83% were U.S. graduates, and 44% had seen>11 (HCV) patients in the past year. Residents tested for HCV in persons with: increased transaminases (83%), history of blood transfusion (46%), multiple tattoos (57%),+ANCA (16%), and alcohol abuse (31%). Sixteen percent of respondents tested all patients. Forty-one percent would vaccinate HCV patients for hepatitis A and 65% for hepatitis B while only 19% and 78% knew the respective vaccination schedules. Although no vaccine is available, 66% recommended vaccination for HCV. Only 37% and 29%, respectively, reported HCV genotype 1 as most common and most resistant to treatment. Fifty-three percent recommend liver biopsy before treating HCV. Only 52% reportedα-interferon (IFN) with ribavirin as initial treatment for HCV while 28% recommend ribavirin or lamivudine alone or combinations of IFN and lamivudine or amantadine. As contraindications to treatment, 33% reported AIDS with PCP infection, 19% coronary artery disease, and 19% suicidal ideation. Sixty-nine percent felt that there was insufficient information on HCV.CONCLUSIONS: Many PC residents lack adequate knowledge of recommended guidelines for the management of HCV. Many test for HCV in inappropriate situations, are unclear regarding available vaccines and their administration, and are uncertain about current treatment. Education of PC residents on guidelines for detection and management of HCV must be improved.(Am J Gastroenterol 2004;99:1720-1725)


Related Articles

  • Patients receiving opioid maintenance treatment in primary care: successful chronic hepatitis C care in a real world setting. Seidenberg, André; Rosemann, Thomas; Senn, Oliver // BMC Infectious Diseases;2013, Vol. 13 Issue 1, p1 

    Background: Injection drug users (IDUs) represent a significant proportion of patients with chronic hepatitis C (CHC). The low treatment uptake among these patients results in a low treatment effectiveness and a limited public health impact. We hypothesised that a general practitioner (GP)...

  • Racial Differences in Response to Interferon-Based Antiviral Therapy for Hepatitis C Virus Infection: A Hardwiring Issue? Tai, Andrew W.; Chung, Raymond T. // Journal of Infectious Diseases;4/15/2009, Vol. 199 Issue 8, p1101 

    In this article the author discusses aspects of hepatitis C virus (HCV) infection in the U.S. Authors are decisive of the measures made by medical experts to achieve effective antiviral therapy. Also explored is the importance of further examination to response the treatment of chronic HCV...

  • Therapeutic vaccines in HBV: lessons from HCV. Barnes, Eleanor // Medical Microbiology & Immunology;Feb2015, Vol. 204 Issue 1, p79 

    Currently, millions of people infected with hepatitis B virus (HBV) are committed to decades of treatment with anti-viral therapy to control viral replication. However, new tools for immunotherapy that include both viral vectors and molecular checkpoint inhibitors are now available. This has led...

  • Hepatitis C: a review for primary care physicians. Wong, Tom; Lee, Samuel S. // CMAJ: Canadian Medical Association Journal;2/28/2006, Vol. 174 Issue 5, p649 

    Abstract Primary care physicians see many of the estimated 250 000 Canadians chronically infected with the hepatitis C virus (HCV). Of this number, about one-third are unaware they are infected, which constitutes a large hidden epidemic. They continue to spread HCV unknowingly and cannot benefit...

  • State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and Immunization. Trucchi, Cecilia; Orsi, Andrea; Alicino, Cristiano; Sticchi, Laura; Icardi, Giancarlo; Ansaldi, Filippo // Journal of Immunology Research;10/24/2016, p1412840 

    Hepatitis C virus (HCV) still represents a major public health threat, with a dramatic burden from both epidemiological and clinical points of view. New generation of direct-acting antiviral agents (DAAs) has been recently introduced in clinical practice promising to cure HCV and to overcome the...

  • Higher cure rates for patients with hepatitis C.  // British Journal of Hospital Medicine (17508460);Nov2008, Vol. 69 Issue 11, p613 

    The article reports on the study presented at American Association for the Study of Liver Diseases by a professor, head of the 1st Division of Gastroenterology and A.M. Migliavacca Center for Liver Disease, University of Milan on the cure rates for patients with hepatitis C. The study found a...

  • Regulatory & Healthcare News.  // PharmacoEconomics & Outcomes News;11/10/2012, Issue 666, p10 

    This section offers regulatory and healthcare news briefs as of November 2012. The Indian government is planning to stop primary care services fees as part of moving towards free universal healthcare provided by government-funded hospitals. Regulatory bodies in South Korea and China recommend...

  • Influenza-Testing and Antiviral-Agent Prescribing Practices -- Connecticut, Minnesota, New Mexico, and New York, 2006-07 Influenza Season. Fazio, D.; Laufer, A.; Meek, J.; Palumbo, J.; Lynfield, R.; Morin, C.; Vick, K.; Baumbach, J.; Mueller, M.; Belflower, R.; Long, C.; Kamimoto, L. // MMWR: Morbidity & Mortality Weekly Report;1/25/2008, Vol. 57 Issue 3, p61 

    The article describes the results of a survey of primary-care physicians (PCP) in selected U.S. states to assess influenza-testing and antiviral-agent prescribing practices during the 2006-2007 influenza season. The results indicated that 69.0% of the PCPs administered influenza tests to...

  • PEGYLOWANY INTERFERON α-2B W LECZENIU PRZEWLEKŁEGO WIRUSOWEGO ZAPALENIA WÄ„TROBY TYPU C U DZIECI. Kupś, Joanna; Woźniakowska-Gęsicka, Teresa // Przeglad Pediatryczny;2008, Vol. 38 Issue 2, p101 

    Introduction: According to clinical investigations, application of peginterferon α-2b and ribavirin in the treatment of chronic hepatitis C allows to achieve sustained virological response in approximately 60% of adult infected with genotype 1 and in 90% of those infected with genotype 2 or...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics